Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial

Abstract Background Trial on five plasma biomarkers (CA125, HE4, OPN, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. Methods In this unicentric prospective trial preoperative blood samples of 43 women with ovarian masses determined for ovarian sur...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	A. Hasenburg, D. Eichkorn, F. Vosshagen, E. Obermayr, A. Geroldinger, R. Zeillinger, M. Bossart
Format:	Article
Language:	English
Published:	BMC 2021-09-01
Subjects:	Ovarian cancer Biomarker Protein panel CA125 Liquid biopsy
Online Access:	https://doi.org/10.1186/s12885-021-08682-y